Bath & Body Works (BBWI) Financials

$33.43 -0.15 (-0.45%)

As of 05/20/2025 03:58 PM Eastern

Annual Income Statements for Bath & Body Works

This table shows Bath & Body Works' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020	2/2/2019	2/3/2018	1/28/2017	1/30/2016
Net Income / (Loss) Attributable to Common Shareholders	798	878	800	1,333	844	-366	644	983	1,158	1,253
Consolidated Net Income / (Loss)	798	878	800	1,333	844	-366	644	983	1,158	1,253
Net Income / (Loss) Continuing Operations	798	878	794	1,075	865	460	644	983	1,158	1,253
Total Pre-Tax Income	1,028	1,021	1,045	1,423	1,122	608	857	1,312	1,696	1,934
Total Operating Income	1,266	1,285	1,376	2,009	1,604	1,040	1,237	1,728	2,003	2,192
Total Gross Profit	3,234	3,236	3,255	3,855	3,096	2,387	4,899	4,959	5,125	5,204
Total Revenue	7,307	7,429	7,560	7,882	6,434	5,405	13,237	12,632	12,574	12,154
Operating Revenue	7,307	7,429	7,560	7,882	6,434	5,405	13,237	12,632	12,574	12,154
Total Cost of Revenue	4,073	4,193	4,305	4,027	3,338	3,018	8,338	7,673	7,449	6,950
Operating Cost of Revenue	4,073	4,193	4,305	4,027	3,338	3,018	8,338	7,673	7,449	6,950
Total Operating Expenses	1,968	1,951	1,879	1,846	1,492	1,347	3,662	3,231	3,122	3,012
Selling, General & Admin Expense	1,968	1,951	1,879	1,846	1,492	1,347	3,563	3,231	3,122	3,012
Total Other Income / (Expense), net	-238	-264	-331	-586	-482	-432	-380	-416	-307	-258
Interest Expense	312	345	348	388	432	370	385	406	394	334
Other Income / (Expense), net	74	81	17	-198	-50	-62	5.00	-10	87	76
Income Tax Expense	230	143	251	348	257	148	213	329	538	681
Net Income / (Loss) Discontinued Operations	0.00	0.00	6.00	258	-21	-826	-	-	-	-
Basic Earnings per Share	$3.62	$3.86	$3.45	$4.96	$3.04	($1.33)	$2.33	$3.46	$4.04	$4.30
Weighted Average Basic Shares Outstanding	214.23M	224.90M	228.77M	238.91M	557.63M	276.53M	276M	284M	287M	291M
Diluted Earnings per Share	$3.61	$3.84	$3.43	$4.88	$3.00	($1.32)	$2.31	$3.42	$3.98	$4.22
Weighted Average Diluted Shares Outstanding	214.23M	224.90M	228.77M	238.91M	557.63M	276.53M	276M	284M	287M	291M
Weighted Average Basic & Diluted Shares Outstanding	214.23M	224.90M	228.77M	238.91M	557.63M	276.53M	276M	284M	287M	291M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80	$0.45	$0.30	$1.20	$2.40	$2.40	$2.40	$2.00

This table shows Bath & Body Works' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Net Income / (Loss) Attributable to Common Shareholders	453	106	152	87	579	119	99	81	434	91
Consolidated Net Income / (Loss)	453	106	152	87	579	119	99	81	434	91
Net Income / (Loss) Continuing Operations	453	106	152	87	579	119	99	81	428	91
Total Pre-Tax Income	612	145	153	118	623	159	127	112	576	119
Total Operating Income	678	218	183	187	695	221	188	181	652	202
Total Gross Profit	1,302	700	626	606	1,336	682	622	596	1,248	678
Total Revenue	2,787	1,610	1,526	1,384	2,912	1,562	1,559	1,396	2,888	1,604
Operating Revenue	2,787	1,610	1,526	1,384	2,912	1,562	1,559	1,396	2,888	1,604
Total Cost of Revenue	1,485	910	900	778	1,576	880	937	800	1,640	926
Operating Cost of Revenue	1,485	910	900	778	1,576	880	937	800	1,640	926
Total Operating Expenses	624	482	443	419	641	461	434	415	596	476
Selling, General & Admin Expense	624	482	443	419	641	461	434	415	596	476
Total Other Income / (Expense), net	-66	-73	-30	-69	-72	-62	-61	-69	-76	-83
Interest Expense	76	77	77	82	86	84	86	89	87	86
Other Income / (Expense), net	10	4.00	47	13	14	22	25	20	11	3.00
Income Tax Expense	159	39	1.00	31	44	40	28	31	148	28
Basic Earnings per Share	$2.06	$0.49	$0.68	$0.39	$2.55	$0.52	$0.43	$0.36	$1.90	$0.40
Weighted Average Basic Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M
Diluted Earnings per Share	$2.06	$0.49	$0.68	$0.38	$2.54	$0.52	$0.43	$0.35	$1.90	$0.40
Weighted Average Diluted Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M
Weighted Average Basic & Diluted Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020	2/2/2019	2/3/2018	1/28/2017	1/30/2016
Net Change in Cash & Equivalents	-410	-148	-747	-1,954	2,434	86	-102	-419	-614	867
Net Cash From Operating Activities	886	954	1,144	1,492	2,039	1,236	1,377	1,406	1,990	2,027
Net Cash From Continuing Operating Activities	886	946	1,144	1,492	2,039	1,236	1,377	1,406	1,990	2,027
Net Income / (Loss) Continuing Operations	798	878	800	1,333	844	-366	644	983	1,158	1,253
Consolidated Net Income / (Loss)	798	878	800	1,333	844	-366	644	983	1,158	1,253
Depreciation Expense	282	269	221	363	521	588	590	571	518	457
Non-Cash Adjustments To Reconcile Net Income	11	9.00	38	241	264	1,147	297	127	16	21
Changes in Operating Assets and Liabilities, net	-205	-210	85	-445	410	-133	-111	-228	344	338
Net Cash From Investing Activities	-162	-286	-328	-259	-219	-480	-609	-698	-833	-443
Net Cash From Continuing Investing Activities	-162	-286	-328	-259	-219	-480	-609	-698	-833	-443
Purchase of Property, Plant & Equipment	-226	-298	-328	-270	-228	-458	-629	-707	-990	-727
Sale and/or Maturity of Investments	40	0.00	0.00	-	-	-	-	-	129	59
Other Investing Activities, net	24	12	0.00	11	9.00	-22	20	9.00	8.00	4.00
Net Cash From Financing Activities	-1,132	-815	-1,562	-3,188	610	-666	-872	-1,127	-1,765	-716
Net Cash From Continuing Financing Activities	-1,132	-815	-1,562	-3,188	610	-666	-872	-1,127	-1,765	-716
Repayment of Debt	-519	-456	2.00	-1,716	-200	-326	-255	-592	-751	986
Repurchase of Common Equity	-401	-148	-1,312	-1,964	0.00	0.00	-198	-446	-435	-483
Payment of Dividends	-177	-182	-186	-120	-83	-332	-666	-686	-1,268	-1,171
Other Financing Activities, net	-35	-29	-66	612	-57	-20	-17	6.00	-38	-55
Effect of Exchange Rate Changes	-2.00	-1.00	-1.00	1.00	4.00	-4.00	2.00	0.00	-6.00	-1.00

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Net Change in Cash & Equivalents	483	-323	-341	-229	672	-378	-256	-186	937	-157
Net Cash From Operating Activities	955	-99	-46	76	926	-49	33	44	1,077	-14
Net Cash From Continuing Operating Activities	955	-99	-46	76	918	-49	33	44	1,077	-14
Net Income / (Loss) Continuing Operations	453	106	152	87	579	119	99	81	434	91
Consolidated Net Income / (Loss)	453	106	152	87	579	119	99	81	434	91
Depreciation Expense	71	69	71	71	70	70	66	63	59	56
Non-Cash Adjustments To Reconcile Net Income	16	9.00	-27	13	8.00	-1.00	2.00	0.00	12	11
Changes in Operating Assets and Liabilities, net	415	-283	-242	-95	261	-237	-134	-100	572	-172
Net Cash From Investing Activities	-48	-74	6.00	-46	-47	-63	-82	-94	-76	-90
Net Cash From Continuing Investing Activities	-48	-74	6.00	-46	-47	-63	-82	-94	-76	-90
Purchase of Property, Plant & Equipment	-60	-65	-55	-46	-48	-72	-85	-93	-76	-91
Other Investing Activities, net	12	1.00	11	0.00	1.00	9.00	3.00	-1.00	-	1.00
Net Cash From Financing Activities	-422	-150	-301	-259	-206	-266	-208	-135	-63	-53
Net Cash From Continuing Financing Activities	-422	-150	-301	-259	-206	-266	-208	-135	-63	-53
Repayment of Debt	-308	-4.00	-96	-111	-93	-169	-113	-81	17	-6.00
Repurchase of Common Equity	-52	-101	-152	-96	-49	-51	-48	0.00	-	-
Payment of Dividends	-43	-44	-45	-45	-45	-45	-46	-46	-46	-46
Other Financing Activities, net	-19	-1.00	-8.00	-7.00	-19	-1.00	-1.00	-8.00	-34	-1.00

This table presents Bath & Body Works' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020	2/2/2019	2/3/2018	1/28/2017	1/30/2016
Total Assets	4,872	5,463	5,494	6,026	11,571	10,125	8,090	8,149	8,170	8,493
Total Current Assets	1,823	2,115	2,266	3,009	5,579	3,245	3,260	3,293	3,465	4,156
Cash & Equivalents	674	1,084	1,232	1,979	3,568	1,499	1,413	1,515	1,934	2,548
Accounts Receivable	205	224	226	240	148	306	367	310	294	261
Inventories, net	734	710	709	709	572	1,287	1,248	1,240	1,096	1,122
Other Current Assets	114	97	99	81	52	153	232	228	141	225
Other Current Nonoperating Assets	96	0.00	-	-	1,239	-	-	-	-	-
Plant, Property, & Equipment, net	1,127	1,220	1,193	1,009	1,017	2,486	2,818	2,893	2,741	2,330
Total Noncurrent Assets	1,922	2,128	2,035	2,008	4,975	4,394	2,012	1,963	1,964	2,007
Goodwill	628	628	628	628	628	628	1,348	1,348	1,348	1,318
Intangible Assets	165	165	165	165	165	411	411	411	411	411
Noncurrent Deferred & Refundable Income Taxes	130	144	37	45	58	84	62	14	19	30
Other Noncurrent Operating Assets	999	1,191	1,205	1,170	1,143	3,271	191	190	186	248
Total Liabilities & Shareholders' Equity	4,872	5,463	5,494	6,026	11,571	10,125	8,090	8,149	8,170	8,493
Total Liabilities	6,255	7,089	7,699	7,543	12,232	11,620	8,955	8,900	8,897	8,751
Total Current Liabilities	1,231	1,289	1,379	1,290	2,826	2,372	1,986	2,031	2,014	1,875
Accounts Payable	338	380	455	435	345	647	711	717	683	668
Accrued Expenses	584	608	673	651	727	1,052	1,082	1,029	997	977
Current Deferred & Payable Income Tax Liabilities	117	120	74	34	83	134	121	198	298	224
Other Current Liabilities	192	181	177	170	173	478	-	-	-	-
Total Noncurrent Liabilities	5,024	5,800	6,320	6,253	9,406	9,248	6,969	6,869	6,883	6,876
Long-Term Debt	3,884	4,388	4,862	4,854	6,366	5,487	5,739	5,707	5,700	5,715
Noncurrent Deferred & Payable Income Tax Liabilities	24	147	168	157	141	219	226	238	352	257
Other Noncurrent Operating Liabilities	1,116	1,265	1,290	1,242	1,232	3,542	1,004	924	831	904
Total Equity & Noncontrolling Interests	-1,383	-1,626	-2,205	-1,517	-661	-1,495	-865	-751	-727	-258
Total Preferred & Common Equity	-1,385	-1,627	-2,206	-1,518	-662	-1,499	-869	-753	-729	-259
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-1,385	-1,627	-2,206	-1,518	-662	-1,499	-869	-753	-729	-259
Common Stock	944	958	939	1,027	1,034	989	912	819	807	701
Retained Earnings	-1,578	-1,838	-2,401	-1,803	-1,421	-2,182	-1,482	-1,434	205	315
Treasury Stock	-822	-822	-822	-822	-358	-358	-358	-162	-1,753	-1,315
Accumulated Other Comprehensive Income / (Loss)	71	75	78	80	83	52	59	24	12	40
Noncontrolling Interest	2.00	1.00	1.00	1.00	1.00	4.00	4.00	2.00	2.00	1.00

This table presents Bath & Body Works' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Total Assets	4,872	4,984	4,948	5,221	5,463	5,243	5,195	5,363	5,494	5,133
Total Current Assets	1,823	1,720	1,666	1,917	2,115	1,959	1,893	2,080	2,266	1,948
Cash & Equivalents	674	191	514	855	1,084	412	790	1,046	1,232	295
Accounts Receivable	205	200	146	121	224	197	153	145	226	242
Inventories, net	734	1,178	863	814	710	1,205	818	771	709	1,269
Other Current Assets	114	151	143	127	97	145	132	118	99	142
Other Current Nonoperating Assets	96	-	-	-	0.00	-	-	-	-	-
Plant, Property, & Equipment, net	1,127	1,158	1,166	1,183	1,220	1,244	1,236	1,223	1,193	1,121
Total Noncurrent Assets	1,922	2,106	2,116	2,121	2,128	2,040	2,066	2,060	2,035	2,064
Goodwill	628	628	628	628	628	628	628	628	628	628
Intangible Assets	165	165	165	165	165	165	165	165	165	165
Noncurrent Deferred & Refundable Income Taxes	130	143	143	143	144	35	38	37	37	41
Other Noncurrent Operating Assets	999	1,170	1,180	1,185	1,191	1,212	1,235	1,230	1,205	1,230
Total Liabilities & Shareholders' Equity	4,872	4,984	4,948	5,221	5,463	5,243	5,195	5,363	5,494	5,133
Total Liabilities	6,255	6,732	6,666	6,897	7,089	7,367	7,349	7,533	7,699	7,741
Total Current Liabilities	1,231	1,575	1,497	1,221	1,289	1,409	1,213	1,277	1,379	1,452
Accounts Payable	338	510	411	403	380	627	508	426	455	632
Accrued Expenses	584	547	526	489	608	590	518	585	673	645
Current Deferred & Payable Income Tax Liabilities	117	16	61	143	120	0.00	0.00	101	74	0.00
Other Current Liabilities	192	188	186	186	181	192	187	165	177	175
Total Noncurrent Liabilities	5,024	5,157	5,169	5,676	5,800	5,958	6,136	6,256	6,320	6,289
Long-Term Debt	3,884	3,883	3,881	4,282	4,388	4,497	4,668	4,781	4,862	4,860
Noncurrent Deferred & Payable Income Tax Liabilities	24	45	45	147	147	167	168	168	168	158
Other Noncurrent Operating Liabilities	1,116	1,229	1,243	1,247	1,265	1,294	1,300	1,307	1,290	1,271
Total Equity & Noncontrolling Interests	-1,383	-1,748	-1,718	-1,676	-1,626	-2,124	-2,154	-2,170	-2,205	-2,608
Total Preferred & Common Equity	-1,385	-1,749	-1,719	-1,677	-1,627	-2,125	-2,155	-2,171	-2,206	-2,609
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-1,385	-1,749	-1,719	-1,677	-1,627	-2,125	-2,155	-2,171	-2,206	-2,609
Common Stock	944	942	947	960	958	951	948	940	939	923
Retained Earnings	-1,578	-1,942	-1,918	-1,889	-1,838	-2,329	-2,358	-2,366	-2,401	-2,789
Treasury Stock	-822	-822	-822	-822	-822	-822	-822	-822	-822	-822
Accumulated Other Comprehensive Income / (Loss)	71	73	74	74	75	75	77	77	78	79
Noncontrolling Interest	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020	2/2/2019	2/3/2018	1/28/2017	1/30/2016
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.64%	-1.73%	-4.09%	22.51%	19.04%	-59.17%	4.79%	0.46%	3.46%	6.11%
EBITDA Growth	-0.80%	1.30%	-25.76%	4.77%	32.50%	-12.47%	-20.21%	-12.49%	-4.51%	13.78%
EBIT Growth	-1.90%	-1.94%	-23.08%	16.54%	58.90%	-21.26%	-27.71%	-17.80%	-7.85%	15.71%
NOPAT Growth	-11.07%	5.69%	-31.11%	22.73%	57.16%	-15.35%	-28.20%	-5.33%	-3.70%	14.17%
Net Income Growth	-9.11%	9.75%	-39.99%	57.94%	330.60%	-156.83%	-34.49%	-15.11%	-7.58%	20.25%
EPS Growth	-5.99%	11.95%	-29.71%	62.67%	330.60%	-156.83%	-32.46%	-14.07%	-5.69%	20.57%
Operating Cash Flow Growth	-7.13%	-16.61%	-23.32%	-26.83%	64.97%	-10.24%	-2.06%	-29.35%	-1.83%	13.49%
Free Cash Flow Firm Growth	9.12%	-12.93%	-21.20%	-54.16%	53.39%	90.99%	9.85%	-30.30%	-22.84%	23.06%
Invested Capital Growth	3.16%	17.75%	4.93%	25.51%	-57.64%	-27.71%	0.14%	14.73%	5.49%	-4.74%
Revenue Q/Q Growth	-1.68%	0.32%	-1.81%	40.40%	124.03%	-58.61%	0.23%	2.71%	0.75%	2.76%
EBITDA Q/Q Growth	-1.22%	3.61%	-11.37%	-22.74%	36.69%	4.19%	-7.35%	-1.80%	-2.62%	5.13%
EBIT Q/Q Growth	-1.54%	3.48%	-13.26%	-23.78%	58.57%	7.00%	-10.39%	-2.55%	-4.00%	5.64%
NOPAT Q/Q Growth	-13.87%	19.20%	-14.29%	-22.71%	43.58%	17.72%	-15.88%	7.26%	0.29%	6.37%
Net Income Q/Q Growth	-13.64%	19.78%	-16.67%	-16.58%	507.73%	-200.00%	-16.15%	3.36%	-0.43%	6.10%
EPS Q/Q Growth	-11.74%	18.52%	-18.33%	-21.29%	507.73%	-200.00%	-17.20%	4.27%	0.51%	100.00%
Operating Cash Flow Q/Q Growth	3.38%	-13.67%	2.88%	-16.18%	0.34%	-2.98%	7.49%	-18.11%	-8.55%	20.80%
Free Cash Flow Firm Q/Q Growth	10.16%	-7.69%	-2.03%	-20.29%	-22.73%	95.26%	11.93%	-27.32%	-1.87%	13.41%
Invested Capital Q/Q Growth	-23.34%	-14.43%	-27.18%	-21.77%	-18.65%	-35.73%	-16.08%	-10.25%	-20.79%	-22.25%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.26%	43.56%	43.06%	48.91%	48.12%	44.16%	37.01%	39.26%	40.76%	42.82%
EBITDA Margin	22.20%	22.01%	21.35%	27.58%	32.25%	28.97%	13.52%	17.75%	20.38%	22.08%
Operating Margin	17.33%	17.30%	18.20%	25.49%	24.93%	19.24%	9.35%	13.68%	15.93%	18.04%
EBIT Margin	18.34%	18.39%	18.43%	22.98%	24.15%	18.09%	9.38%	13.60%	16.62%	18.66%
Profit (Net Income) Margin	10.92%	11.82%	10.58%	16.91%	13.12%	-6.77%	4.87%	7.78%	9.21%	10.31%
Tax Burden Percent	77.63%	85.99%	76.56%	93.68%	75.22%	-60.20%	75.15%	74.92%	68.28%	64.79%
Interest Burden Percent	76.72%	74.74%	75.02%	78.58%	72.20%	62.17%	69.00%	76.37%	81.15%	85.27%
Effective Tax Rate	22.37%	14.01%	24.02%	24.46%	22.91%	24.34%	24.85%	25.08%	31.72%	35.21%
Return on Invested Capital (ROIC)	57.66%	71.22%	75.13%	124.40%	68.02%	25.85%	26.33%	39.22%	45.66%	47.54%
ROIC Less NNEP Spread (ROIC-NNEP)	51.90%	64.67%	67.59%	116.40%	54.46%	-1.44%	19.75%	31.50%	39.65%	42.16%
Return on Net Nonoperating Assets (RNNOA)	-110.70%	-117.06%	-118.12%	-246.81%	-146.31%	5.16%	-106.03%	-172.23%	-280.79%	-1,096.07%
Return on Equity (ROE)	-53.04%	-45.84%	-42.99%	-122.41%	-78.29%	31.02%	-79.70%	-133.02%	-235.13%	-1,048.54%
Cash Return on Invested Capital (CROIC)	54.55%	54.92%	70.32%	101.78%	148.99%	58.02%	26.19%	25.49%	40.32%	52.39%
Operating Return on Assets (OROA)	25.93%	24.93%	24.18%	20.58%	14.33%	10.74%	15.30%	21.06%	25.09%	28.41%
Return on Assets (ROA)	15.44%	16.03%	13.89%	15.15%	7.78%	-4.02%	7.93%	12.05%	13.90%	15.69%
Return on Common Equity (ROCE)	-53.09%	-45.86%	-43.01%	-122.52%	-78.47%	31.12%	-80.00%	-133.38%	-235.84%	-1,057.31%
Return on Equity Simple (ROE_SIMPLE)	-57.62%	-53.96%	-36.26%	-87.81%	-127.49%	24.42%	-74.11%	-130.54%	-158.85%	-483.78%
Net Operating Profit after Tax (NOPAT)	983	1,105	1,045	1,518	1,237	787	930	1,295	1,368	1,420
NOPAT Margin	13.45%	14.87%	13.83%	19.26%	19.22%	14.56%	7.02%	10.25%	10.88%	11.68%
Net Nonoperating Expense Percent (NNEP)	5.76%	6.55%	7.55%	8.00%	13.56%	27.30%	6.58%	7.71%	6.01%	5.38%
Return On Investment Capital (ROIC_SIMPLE)	39.29%	40.01%	39.35%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	55.74%	56.44%	56.94%	51.09%	51.88%	55.84%	62.99%	60.74%	59.24%	57.18%
SG&A Expenses to Revenue	26.93%	26.26%	24.85%	23.42%	23.19%	24.92%	26.92%	25.58%	24.83%	24.78%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.93%	26.26%	24.85%	23.42%	23.19%	24.92%	27.66%	25.58%	24.83%	24.78%
Earnings before Interest and Taxes (EBIT)	1,340	1,366	1,393	1,811	1,554	978	1,242	1,718	2,090	2,268
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,622	1,635	1,614	2,174	2,075	1,566	1,789	2,242	2,562	2,683
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.17	1.30	1.29	1.71	1.34	0.89	0.40	0.70	0.84	1.36
Price to Earnings (P/E)	10.71	11.01	12.15	10.09	10.19	0.00	8.20	9.00	9.15	13.17
Dividend Yield	2.14%	1.89%	1.88%	0.80%	3.10%	5.53%	10.00%	6.13%	5.18%	2.81%
Earnings Yield	9.34%	9.08%	8.23%	9.91%	9.82%	0.00%	12.20%	11.11%	10.93%	7.60%
Enterprise Value to Invested Capital (EV/IC)	6.79	7.73	9.37	12.02	10.53	3.47	2.74	3.72	4.68	6.75
Enterprise Value to Revenue (EV/Rev)	1.61	1.75	1.77	2.07	1.77	1.64	0.73	1.04	1.14	1.62
Enterprise Value to EBITDA (EV/EBITDA)	7.25	7.94	8.27	7.51	5.49	5.65	5.41	5.85	5.62	7.33
Enterprise Value to EBIT (EV/EBIT)	8.78	9.50	9.59	9.01	7.33	9.05	7.80	7.64	6.89	8.67
Enterprise Value to NOPAT (EV/NOPAT)	11.97	11.74	12.77	10.76	9.22	11.25	10.42	10.14	10.53	13.85
Enterprise Value to Operating Cash Flow (EV/OCF)	13.27	13.60	11.67	10.94	5.59	7.16	7.03	9.34	7.23	9.70
Enterprise Value to Free Cash Flow (EV/FCFF)	12.65	15.23	13.65	13.15	4.21	5.01	10.47	15.60	11.92	12.57
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.81	-2.70	-2.21	-3.20	-9.63	-3.71	-6.72	-7.72	-7.89	-22.17
Long-Term Debt to Equity	-2.81	-2.70	-2.21	-3.20	-9.63	-3.67	-6.63	-7.60	-7.84	-22.15
Financial Leverage	-2.13	-1.81	-1.75	-2.12	-2.69	-3.58	-5.37	-5.47	-7.08	-26.00
Leverage Ratio	-3.43	-2.86	-3.10	-8.08	-10.06	-7.72	-10.05	-11.04	-16.92	-66.82
Compound Leverage Factor	-2.64	-2.14	-2.32	-6.35	-7.27	-4.80	-6.93	-8.43	-13.73	-56.98
Debt to Total Capital	155.30%	158.87%	182.99%	145.46%	111.59%	136.89%	117.49%	114.89%	114.51%	104.72%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	1.51%	1.46%	1.73%	0.72%	0.11%
Long-Term Debt to Total Capital	155.30%	158.87%	182.99%	145.46%	111.59%	135.38%	116.03%	113.17%	113.80%	104.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.08%	0.04%	0.04%	0.03%	0.02%	0.10%	0.08%	0.04%	0.04%	0.02%
Common Equity to Total Capital	-55.38%	-58.91%	-83.03%	-45.49%	-11.60%	-36.98%	-17.57%	-14.93%	-14.55%	-4.74%
Debt to EBITDA	2.39	2.68	3.01	2.23	3.07	3.54	3.25	2.58	2.24	2.13
Net Debt to EBITDA	1.98	2.02	2.25	1.32	1.35	2.59	2.46	1.91	1.48	1.18
Long-Term Debt to EBITDA	2.39	2.68	3.01	2.23	3.07	3.50	3.21	2.55	2.22	2.13
Debt to NOPAT	3.95	3.97	4.65	3.20	5.15	7.05	6.25	4.48	4.19	4.03
Net Debt to NOPAT	3.27	2.99	3.47	1.89	2.26	5.15	4.73	3.31	2.78	2.23
Long-Term Debt to NOPAT	3.95	3.97	4.65	3.20	5.15	6.97	6.17	4.41	4.17	4.02
Altman Z-Score	2.92	2.71	2.55	3.29	1.53	0.90	2.43	2.78	3.35	3.82
Noncontrolling Interest Sharing Ratio	-0.10%	-0.05%	-0.05%	-0.09%	-0.23%	-0.34%	-0.37%	-0.27%	-0.30%	-0.84%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.48	1.64	1.64	2.33	1.97	1.37	1.64	1.62	1.72	2.22
Quick Ratio	0.71	1.01	1.06	1.72	1.31	0.76	0.90	0.90	1.11	1.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	930	852	978	1,242	2,709	1,766	925	842	1,208	1,565
Operating Cash Flow to CapEx	392.04%	320.13%	348.78%	552.59%	894.30%	269.87%	218.92%	198.87%	212.38%	381.73%
Free Cash Flow to Firm to Interest Expense	2.98	2.47	2.81	3.20	6.27	4.77	2.40	2.07	3.07	4.69
Operating Cash Flow to Interest Expense	2.84	2.77	3.29	3.85	4.72	3.34	3.58	3.46	5.05	6.07
Operating Cash Flow Less CapEx to Interest Expense	2.12	1.90	2.34	3.15	4.19	2.10	1.94	1.72	2.67	4.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.41	1.36	1.31	0.90	0.59	0.59	1.63	1.55	1.51	1.52
Accounts Receivable Turnover	34.07	33.02	32.45	40.63	28.34	16.06	39.10	41.83	45.31	47.38
Inventory Turnover	5.64	5.91	6.07	6.29	3.59	2.38	6.70	6.57	6.72	6.44
Fixed Asset Turnover	6.23	6.16	6.87	7.78	3.67	2.04	4.64	4.48	4.96	5.28
Accounts Payable Turnover	11.35	10.04	9.67	10.33	6.73	4.44	11.68	10.96	11.03	10.85
Days Sales Outstanding (DSO)	10.71	11.05	11.25	8.98	12.88	22.72	9.33	8.73	8.06	7.70
Days Inventory Outstanding (DIO)	64.70	61.76	60.11	58.05	101.64	153.29	54.46	55.56	54.34	56.67
Days Payable Outstanding (DPO)	32.17	36.34	37.73	35.35	54.24	82.12	31.26	33.30	33.10	33.64
Cash Conversion Cycle (CCC)	43.24	36.47	33.63	31.69	60.28	93.90	32.53	30.99	29.30	30.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,731	1,678	1,425	1,358	1,082	2,554	3,533	3,528	3,075	2,915
Invested Capital Turnover	4.29	4.79	5.43	6.46	3.54	1.78	3.75	3.83	4.20	4.07
Increase / (Decrease) in Invested Capital	53	253	67	276	-1,472	-979	5.00	453	160	-145
Enterprise Value (EV)	11,760	12,975	13,353	16,324	11,398	8,851	9,682	13,126	14,396	19,672
Market Capitalization	8,548	9,670	9,722	13,448	8,599	4,798	5,280	8,845	10,592	16,498
Book Value per Share	($6.39)	($7.20)	($9.66)	($5.89)	($2.38)	($5.42)	($3.16)	($2.67)	($2.55)	($0.89)
Tangible Book Value per Share	($10.06)	($10.71)	($13.13)	($8.97)	($5.23)	($9.18)	($9.55)	($8.90)	($8.70)	($6.87)
Total Capital	2,501	2,762	2,657	3,337	5,705	4,053	4,946	5,043	5,009	5,463
Total Debt	3,884	4,388	4,862	4,854	6,366	5,548	5,811	5,794	5,736	5,721
Total Long-Term Debt	3,884	4,388	4,862	4,854	6,366	5,487	5,739	5,707	5,700	5,715
Net Debt	3,210	3,304	3,630	2,875	2,798	4,049	4,398	4,279	3,802	3,173
Capital Expenditures (CapEx)	226	298	328	270	228	458	629	707	937	531
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-82	-258	-345	-260	-815	-565	-67	-166	-447	-261
Debt-free Net Working Capital (DFNWC)	592	826	887	1,719	2,753	934	1,346	1,349	1,487	2,287
Net Working Capital (NWC)	592	826	887	1,719	2,753	873	1,274	1,262	1,451	2,281
Net Nonoperating Expense (NNE)	185	227	245	185	393	1,153	286	312	210	167
Net Nonoperating Obligations (NNO)	3,114	3,304	3,630	2,875	1,743	4,049	4,398	4,279	3,802	3,173
Total Depreciation and Amortization (D&A)	282	269	221	363	521	588	547	524	472	415
Debt-free, Cash-free Net Working Capital to Revenue	-1.12%	-3.47%	-4.56%	-3.30%	-12.67%	-10.45%	-0.51%	-1.31%	-3.56%	-2.15%
Debt-free Net Working Capital to Revenue	8.10%	11.12%	11.73%	21.81%	42.79%	17.28%	10.17%	10.68%	11.83%	18.82%
Net Working Capital to Revenue	8.10%	11.12%	11.73%	21.81%	42.79%	16.15%	9.62%	9.99%	11.54%	18.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.62	$3.86	$0.00	$4.96	$2.43	($1.06)	$1.86	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	214.23M	224.90M	0.00	238.91M	697.21M	345.75M	344.08M	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$3.61	$3.84	$0.00	$4.88	$2.40	($1.06)	$1.85	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	214.23M	224.90M	0.00	238.91M	697.21M	345.75M	344.08M	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	214.23M	224.90M	0.00	238.91M	697.21M	345.75M	344.08M	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	983	1,105	1,045	1,518	1,237	787	1,004	1,295	1,368	1,420
Normalized NOPAT Margin	13.45%	14.87%	13.83%	19.26%	19.22%	14.56%	7.58%	10.25%	10.88%	11.68%
Pre Tax Income Margin	14.07%	13.74%	13.82%	18.05%	17.44%	11.25%	6.47%	10.39%	13.49%	15.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.29	3.96	4.00	4.67	3.60	2.64	3.23	4.23	5.30	6.79
NOPAT to Interest Expense	3.15	3.20	3.00	3.91	2.86	2.13	2.41	3.19	3.47	4.25
EBIT Less CapEx to Interest Expense	3.57	3.10	3.06	3.97	3.07	1.41	1.59	2.49	2.93	5.20
NOPAT Less CapEx to Interest Expense	2.43	2.34	2.06	3.22	2.33	0.89	0.78	1.45	1.09	2.66
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.18%	20.73%	23.25%	9.00%	9.83%	-90.71%	103.42%	69.79%	109.50%	93.46%
Augmented Payout Ratio	72.43%	37.59%	187.25%	156.34%	9.83%	-90.71%	134.16%	115.16%	147.06%	132.00%

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.29%	3.07%	-2.12%	-0.86%	0.83%	-2.62%	-3.65%	-3.72%	-4.59%	-4.58%
EBITDA Growth	-2.57%	-7.03%	7.89%	2.65%	7.89%	19.92%	-6.06%	-20.96%	-22.28%	-29.46%
EBIT Growth	-2.96%	-8.64%	7.98%	-0.50%	6.94%	18.54%	-12.70%	-28.47%	-24.32%	-35.53%
NOPAT Growth	-22.30%	-3.65%	24.05%	5.33%	33.32%	7.08%	-20.26%	-42.09%	-26.45%	-51.56%
Net Income Growth	-21.76%	-10.92%	53.54%	7.41%	33.41%	30.77%	-17.50%	-47.74%	-26.94%	3.41%
EPS Growth	-18.90%	-5.77%	58.14%	8.57%	33.68%	30.00%	-17.31%	-45.31%	-23.69%	21.21%
Operating Cash Flow Growth	3.13%	-102.04%	-239.39%	72.73%	-14.02%	-250.00%	120.00%	-33.33%	3.06%	88.89%
Free Cash Flow Firm Growth	14.24%	-185.27%	-133.74%	-142.63%	-5.88%	342.60%	158.60%	150.87%	9.09%	23.61%
Invested Capital Growth	3.16%	15.15%	13.81%	11.89%	17.75%	0.20%	-1.15%	1.16%	4.93%	12.73%
Revenue Q/Q Growth	73.11%	5.50%	10.26%	-52.47%	86.43%	0.19%	11.68%	-51.66%	80.05%	-0.87%
EBITDA Q/Q Growth	160.82%	-3.32%	11.07%	-65.21%	148.88%	12.19%	5.68%	-63.43%	176.63%	-12.12%
EBIT Q/Q Growth	209.91%	-3.48%	15.00%	-71.79%	191.77%	14.08%	5.97%	-69.68%	223.41%	-15.98%
NOPAT Q/Q Growth	214.91%	-12.34%	31.86%	-78.65%	290.51%	12.86%	11.96%	-72.98%	213.63%	-15.96%
Net Income Q/Q Growth	327.36%	-30.26%	74.71%	-84.97%	386.55%	20.20%	22.22%	-81.34%	376.92%	-24.17%
EPS Q/Q Growth	320.41%	-27.94%	78.95%	-85.04%	388.46%	20.93%	22.86%	-81.58%	375.00%	-23.08%
Operating Cash Flow Q/Q Growth	1,064.65%	-115.22%	-160.53%	-91.79%	1,989.80%	-248.48%	-25.00%	-95.91%	7,792.86%	-193.33%
Free Cash Flow Firm Q/Q Growth	426.12%	-144.92%	-16.77%	-112.25%	143.44%	-3.09%	47.52%	-72.96%	727.50%	76.59%
Invested Capital Q/Q Growth	-23.34%	15.09%	12.05%	4.35%	-14.43%	13.75%	10.16%	9.82%	-27.18%	12.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.72%	43.48%	41.02%	43.79%	45.88%	43.66%	39.90%	42.69%	43.21%	42.27%
EBITDA Margin	27.23%	18.07%	19.72%	19.58%	26.75%	20.04%	17.90%	18.91%	25.00%	16.27%
Operating Margin	24.33%	13.54%	11.99%	13.51%	23.87%	14.15%	12.06%	12.97%	22.58%	12.59%
EBIT Margin	24.69%	13.79%	15.07%	14.45%	24.35%	15.56%	13.66%	14.40%	22.96%	12.78%
Profit (Net Income) Margin	16.25%	6.58%	9.96%	6.29%	19.88%	7.62%	6.35%	5.80%	15.03%	5.67%
Tax Burden Percent	74.02%	73.10%	99.35%	73.73%	92.94%	74.84%	77.95%	72.32%	75.35%	76.47%
Interest Burden Percent	88.95%	65.32%	66.52%	59.00%	87.87%	65.43%	59.62%	55.72%	86.88%	58.05%
Effective Tax Rate	25.98%	26.90%	0.65%	26.27%	7.06%	25.16%	22.05%	27.68%	25.69%	23.53%
Return on Invested Capital (ROIC)	77.19%	34.87%	47.73%	44.56%	106.21%	40.03%	40.37%	45.23%	91.14%	40.15%
ROIC Less NNEP Spread (ROIC-NNEP)	75.67%	33.55%	46.94%	43.14%	104.28%	38.95%	39.22%	43.98%	89.59%	38.56%
Return on Net Nonoperating Assets (RNNOA)	-161.40%	-70.12%	-91.63%	-80.34%	-188.74%	-71.21%	-67.47%	-72.32%	-156.58%	-71.81%
Return on Equity (ROE)	-84.21%	-35.24%	-43.90%	-35.78%	-82.53%	-31.18%	-27.10%	-27.09%	-65.44%	-31.66%
Cash Return on Invested Capital (CROIC)	54.55%	40.01%	49.18%	55.80%	54.92%	47.12%	53.94%	60.08%	70.32%	54.09%
Operating Return on Assets (OROA)	34.91%	20.04%	21.94%	20.25%	33.02%	22.21%	20.16%	21.14%	30.13%	17.63%
Return on Assets (ROA)	22.98%	9.57%	14.50%	8.81%	26.96%	10.87%	9.37%	8.52%	19.72%	7.82%
Return on Common Equity (ROCE)	-84.29%	-35.26%	-43.92%	-35.80%	-82.58%	-31.19%	-27.11%	-27.10%	-65.47%	-31.67%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-52.83%	-54.51%	-52.71%	0.00%	-34.49%	-32.71%	-33.44%	0.00%	-36.80%
Net Operating Profit after Tax (NOPAT)	502	159	182	138	646	165	147	131	484	154
NOPAT Margin	18.01%	9.90%	11.91%	9.96%	22.18%	10.59%	9.40%	9.38%	16.78%	9.63%
Net Nonoperating Expense Percent (NNEP)	1.52%	1.32%	0.79%	1.42%	1.93%	1.07%	1.15%	1.26%	1.55%	1.59%
Return On Investment Capital (ROIC_SIMPLE)	20.07%	-	-	-	23.39%	-	-	-	18.23%	-
Cost of Revenue to Revenue	53.28%	56.52%	58.98%	56.21%	54.12%	56.34%	60.10%	57.31%	56.79%	57.73%
SG&A Expenses to Revenue	22.39%	29.94%	29.03%	30.27%	22.01%	29.51%	27.84%	29.73%	20.64%	29.68%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.39%	29.94%	29.03%	30.27%	22.01%	29.51%	27.84%	29.73%	20.64%	29.68%
Earnings before Interest and Taxes (EBIT)	688	222	230	200	709	243	213	201	663	205
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	759	291	301	271	779	313	279	264	722	261
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.17	0.88	1.02	1.42	1.30	0.85	1.09	1.05	1.29	0.96
Price to Earnings (P/E)	10.71	7.10	8.05	11.88	11.01	8.58	11.53	10.81	12.15	7.73
Dividend Yield	2.14%	2.78%	2.42%	1.74%	1.89%	2.91%	2.25%	2.33%	1.88%	2.31%
Earnings Yield	9.34%	14.08%	12.43%	8.42%	9.08%	11.66%	8.67%	9.25%	8.23%	12.93%
Enterprise Value to Invested Capital (EV/IC)	6.79	4.68	5.72	7.95	7.73	5.29	6.97	7.40	9.37	6.13
Enterprise Value to Revenue (EV/Rev)	1.61	1.42	1.52	1.88	1.75	1.40	1.61	1.54	1.77	1.56
Enterprise Value to EBITDA (EV/EBITDA)	7.25	6.44	6.74	8.48	7.94	6.57	7.87	7.50	8.27	6.59
Enterprise Value to EBIT (EV/EBIT)	8.78	7.77	8.12	10.20	9.50	7.86	9.37	8.82	9.59	7.47
Enterprise Value to NOPAT (EV/NOPAT)	11.97	9.26	9.80	12.53	11.74	11.19	13.12	12.16	12.77	9.83
Enterprise Value to Operating Cash Flow (EV/OCF)	13.27	12.33	12.37	14.13	13.60	9.39	10.54	10.32	11.67	10.78
Enterprise Value to Free Cash Flow (EV/FCFF)	12.65	12.52	12.38	15.05	15.23	11.24	12.84	12.39	13.65	12.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.81	-2.40	-2.44	-2.55	-2.70	-2.12	-2.17	-2.20	-2.21	-1.86
Long-Term Debt to Equity	-2.81	-2.22	-2.26	-2.55	-2.70	-2.12	-2.17	-2.20	-2.21	-1.86
Financial Leverage	-2.13	-2.09	-1.95	-1.86	-1.81	-1.83	-1.72	-1.64	-1.75	-1.86
Leverage Ratio	-3.43	-2.64	-2.62	-2.75	-2.86	-2.19	-2.10	-2.12	-3.10	-2.61
Compound Leverage Factor	-3.06	-1.73	-1.74	-1.62	-2.51	-1.43	-1.25	-1.18	-2.69	-1.51
Debt to Total Capital	155.30%	171.38%	169.39%	164.31%	158.87%	189.51%	185.68%	183.11%	182.99%	215.81%
Short-Term Debt to Total Capital	0.00%	12.82%	12.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	155.30%	158.55%	156.74%	164.31%	158.87%	189.51%	185.68%	183.11%	182.99%	215.81%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.08%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
Common Equity to Total Capital	-55.38%	-71.42%	-69.43%	-64.35%	-58.91%	-89.55%	-85.72%	-83.15%	-83.03%	-115.85%
Debt to EBITDA	2.39	2.56	2.52	2.61	2.68	2.85	3.06	3.10	3.01	2.67
Net Debt to EBITDA	1.98	2.44	2.21	2.09	2.02	2.59	2.54	2.42	2.25	2.51
Long-Term Debt to EBITDA	2.39	2.36	2.33	2.61	2.68	2.85	3.06	3.10	3.01	2.67
Debt to NOPAT	3.95	3.68	3.67	3.85	3.97	4.85	5.10	5.02	4.65	3.98
Net Debt to NOPAT	3.27	3.51	3.22	3.08	2.99	4.41	4.24	3.92	3.47	3.74
Long-Term Debt to NOPAT	3.95	3.40	3.39	3.85	3.97	4.85	5.10	5.02	4.65	3.98
Altman Z-Score	2.48	1.71	1.82	2.11	2.32	1.58	1.75	1.71	2.11	1.56
Noncontrolling Interest Sharing Ratio	-0.10%	-0.05%	-0.05%	-0.05%	-0.05%	-0.04%	-0.04%	-0.04%	-0.05%	-0.05%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.48	1.09	1.11	1.57	1.64	1.39	1.56	1.63	1.64	1.34
Quick Ratio	0.71	0.25	0.44	0.80	1.01	0.43	0.78	0.93	1.06	0.37
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	449	-138	-56	-48	393	161	167	113	417	-67
Operating Cash Flow to CapEx	1,591.67%	-152.31%	-83.64%	165.22%	1,929.17%	-68.06%	38.82%	47.31%	1,417.11%	-15.38%
Free Cash Flow to Firm to Interest Expense	5.91	-1.79	-0.73	-0.59	4.57	1.92	1.94	1.27	4.80	-0.77
Operating Cash Flow to Interest Expense	12.57	-1.29	-0.60	0.93	10.77	-0.58	0.38	0.49	12.38	-0.16
Operating Cash Flow Less CapEx to Interest Expense	11.78	-2.13	-1.31	0.37	10.21	-1.44	-0.60	-0.55	11.51	-1.22
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.41	1.45	1.46	1.40	1.36	1.43	1.48	1.47	1.31	1.38
Accounts Receivable Turnover	34.07	37.44	49.39	55.77	33.02	33.74	44.20	48.12	32.45	31.81
Inventory Turnover	5.64	3.49	4.92	5.26	5.91	3.44	4.81	5.44	6.07	3.51
Fixed Asset Turnover	6.23	6.19	6.15	6.17	6.16	6.26	6.46	6.58	6.87	7.20
Accounts Payable Turnover	11.35	7.32	9.00	10.06	10.04	6.76	7.86	9.65	9.67	6.60
Days Sales Outstanding (DSO)	10.71	9.75	7.39	6.55	11.05	10.82	8.26	7.59	11.25	11.47
Days Inventory Outstanding (DIO)	64.70	104.44	74.21	69.35	61.76	106.06	75.88	67.15	60.11	103.93
Days Payable Outstanding (DPO)	32.17	49.83	40.57	36.27	36.34	53.97	46.44	37.82	37.73	55.32
Cash Conversion Cycle (CCC)	43.24	64.36	41.03	39.62	36.47	62.91	37.69	36.92	33.63	60.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,731	2,258	1,962	1,751	1,678	1,961	1,724	1,565	1,425	1,957
Invested Capital Turnover	4.29	3.52	4.01	4.47	4.79	3.78	4.29	4.82	5.43	4.17
Increase / (Decrease) in Invested Capital	53	297	238	186	253	4.00	-20	18	67	221
Enterprise Value (EV)	11,760	10,570	11,220	13,928	12,975	10,374	12,011	11,583	13,353	11,991
Market Capitalization	8,548	6,563	7,539	10,500	9,670	6,288	8,132	7,847	9,722	7,425
Book Value per Share	($6.39)	($7.98)	($7.70)	($7.46)	($7.20)	($9.35)	($9.41)	($9.49)	($9.66)	($11.42)
Tangible Book Value per Share	($10.06)	($11.60)	($11.25)	($10.98)	($10.71)	($12.83)	($12.88)	($12.96)	($13.13)	($14.90)
Total Capital	2,501	2,449	2,476	2,606	2,762	2,373	2,514	2,611	2,657	2,252
Total Debt	3,884	4,197	4,194	4,282	4,388	4,497	4,668	4,781	4,862	4,860
Total Long-Term Debt	3,884	3,883	3,881	4,282	4,388	4,497	4,668	4,781	4,862	4,860
Net Debt	3,210	4,006	3,680	3,427	3,304	4,085	3,878	3,735	3,630	4,565
Capital Expenditures (CapEx)	60	65	55	46	48	72	85	93	76	91
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-82	268	-32	-159	-258	138	-110	-243	-345	201
Debt-free Net Working Capital (DFNWC)	592	459	482	696	826	550	680	803	887	496
Net Working Capital (NWC)	592	145	169	696	826	550	680	803	887	496
Net Nonoperating Expense (NNE)	49	53	30	51	67	46	48	50	50	63
Net Nonoperating Obligations (NNO)	3,114	4,006	3,680	3,427	3,304	4,085	3,878	3,735	3,630	4,565
Total Depreciation and Amortization (D&A)	71	69	71	71	70	70	66	63	59	56
Debt-free, Cash-free Net Working Capital to Revenue	-1.12%	3.61%	-0.43%	-2.14%	-3.47%	1.86%	-1.48%	-3.24%	-4.56%	2.61%
Debt-free Net Working Capital to Revenue	8.10%	6.18%	6.53%	9.38%	11.12%	7.43%	9.13%	10.70%	11.73%	6.44%
Net Working Capital to Revenue	8.10%	1.95%	2.29%	9.38%	11.12%	7.43%	9.13%	10.70%	11.73%	6.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.06	$0.49	$0.68	$0.39	$2.55	$0.52	$0.43	$0.36	$1.90	$0.40
Adjusted Weighted Average Basic Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M
Adjusted Diluted Earnings per Share	$2.06	$0.49	$0.68	$0.38	$2.54	$0.52	$0.43	$0.35	$1.90	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.90	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	214.23M	216.58M	219.11M	223.23M	224.90M	225.94M	227.38M	228.91M	228.77M	228.41M
Normalized Net Operating Profit after Tax (NOPAT)	502	159	182	138	646	165	147	131	484	154
Normalized NOPAT Margin	18.01%	9.90%	11.91%	9.96%	22.18%	10.59%	9.40%	9.38%	16.78%	9.63%
Pre Tax Income Margin	21.96%	9.01%	10.03%	8.53%	21.39%	10.18%	8.15%	8.02%	19.94%	7.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.05	2.88	2.99	2.44	8.24	2.89	2.48	2.26	7.62	2.38
NOPAT to Interest Expense	6.60	2.07	2.36	1.68	7.51	1.97	1.70	1.47	5.57	1.80
EBIT Less CapEx to Interest Expense	8.26	2.04	2.27	1.88	7.69	2.04	1.49	1.21	6.75	1.33
NOPAT Less CapEx to Interest Expense	5.81	1.23	1.65	1.12	6.95	1.11	0.72	0.43	4.70	0.74
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.18%	19.37%	19.21%	20.48%	20.73%	24.97%	26.10%	25.34%	23.25%	18.65%
Augmented Payout Ratio	72.43%	62.45%	56.35%	48.08%	37.59%	38.47%	32.91%	37.05%	187.25%	199.06%

Frequently Asked Questions About Bath & Body Works' Financials

When does Bath & Body Works's financial year end?

According to the most recent income statement we have on file, Bath & Body Works' fiscal year ends in February. Their fiscal year 2025 ended on February 1, 2025.

How has Bath & Body Works' net income changed over the last 9 years?

Bath & Body Works' net income appears to be on a downward trend, with a most recent value of $798 million in 2024, falling from $1.25 billion in 2015. The previous period was $878 million in 2023. Find out what analysts predict for Bath & Body Works in the coming months.

What is Bath & Body Works's operating income?

Bath & Body Works's total operating income in 2024 was $1.27 billion, based on the following breakdown:

Total Gross Profit: $3.23 billion
Total Operating Expenses: $1.97 billion

How has Bath & Body Works revenue changed over the last 9 years?

Over the last 9 years, Bath & Body Works' total revenue changed from $12.15 billion in 2015 to $7.31 billion in 2024, a change of -39.9%.

How much debt does Bath & Body Works have?

Bath & Body Works' total liabilities were at $6.26 billion at the end of 2024, a 11.8% decrease from 2023, and a 28.5% decrease since 2015.

How much cash does Bath & Body Works have?

In the past 9 years, Bath & Body Works' cash and equivalents has ranged from $674 million in 2024 to $3.57 billion in 2020, and is currently $674 million as of their latest financial filing in 2024.

How has Bath & Body Works' book value per share changed over the last 9 years?

Over the last 9 years, Bath & Body Works' book value per share changed from -0.89 in 2015 to -6.39 in 2024, a change of 614.7%.

Related Companies

This page (NYSE:BBWI) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bath & Body Works (BBWI) Financials

Frequently Asked Questions About Bath & Body Works' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bath & Body Works (BBWI) Financials

Annual Income Statements for Bath & Body Works

Quarterly Income Statements for Bath & Body Works

Annual Cash Flow Statements for Bath & Body Works

Quarterly Cash Flow Statements for Bath & Body Works

Annual Balance Sheets for Bath & Body Works

Quarterly Balance Sheets for Bath & Body Works

Annual Metrics And Ratios for Bath & Body Works

Quarterly Metrics And Ratios for Bath & Body Works

Frequently Asked Questions About Bath & Body Works' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools